TokenPost topic
MEDICAL DEVICES
19 TokenPost stories are tagged MEDICAL DEVICES. The newest appear first.
Latest MEDICAL DEVICES stories
- PAVmed Advances Veris Implantable Monitor Toward Early 2027 FDA Filing
Veris Health’s monitor reached design freeze, and a 90-day GLP animal study began in October.
· Business
- Tandem Diabetes Care Shares Rise 12% After Tubeless Mobi Clearance
Tandem said the U.S. Food and Drug Administration granted 510(k) clearance for the tubeless system. Shares reached $19.62 at 9:59 a.m. ET.
· Regulation
- NeuroPace Cuts 2026 Revenue Outlook to $91 Million-$92 Million
The company expects RNS System revenue to grow about 15% in 2027, with growth accelerating toward 20% by year-end.
· Business
- Tenon Medical Targets Quickstep Launch in Q1 2027 as It Plans Sales Hiring
Tenon plans to add sales representatives and distributors while targeting an early December submission for a SImmetry+ implant enhancement.
· Business
- Orthofix Q3 Revenue Misses Estimates by $2.62 Million as EPS Beats
Revenue rose 1.1% year over year. Cash, cash equivalents and restricted cash fell to $86.9 million at Sept. 30 from $104.4 million at June 30.
· Business
- Elutia Targets Q4 FDA Filing for Antibiotic-Coated NXT-41x Matrix
CEO Dr. Randy Mills projected a clearance decision in Q2 2027, within Elutia's broader first-half target. The reported antibacterial results came from a rabbit study.
· Business
- Artivion Narrows 2026 Revenue Outlook Ahead of NEXUS Launch
Third-quarter revenue rose 9% to $123.8 million, while adjusted EBITDA fell 8% to $22.5 million. The U.S. launch is planned for January 2027.
· Business
- Apyx Lowers 2026 Expense Target, Keeps Revenue Outlook at $59 Million to $60 Million
Third-quarter revenue rose 9% year over year to $14 million, led by a 17% gain in Surgical Aesthetics revenue.
· Business
- Edwards Lifesciences Lifts 2026 Constant-Currency Sales-Growth Outlook to About 11.5%
The company also raised its TAVR growth range and projected TMTT sales of $780 million to $790 million.
· Business
- Sight Sciences Raises 2026 Revenue Outlook to $92 Million to $93 Million
It raised IDE revenue guidance to about $12 million and kept adjusted operating expense guidance unchanged.
· Business
- Utah Medical Products Raises Quarterly Dividend 1.6% to $0.315
The payment is scheduled for Jan. 5, with Dec. 17 set as both the record date and ex-dividend date.
· Business
- Rockwell Medical Sets $125 Million Base Price for Hemodialysis Deal
The acquisition adds machines, water treatment systems and services to Rockwell’s portfolio. It includes a manufacturing facility in Italy and is expected to close in mid-2027.
· Business
- Bioventus Lowers 2026 Revenue Outlook to $590 Million-$595 Million
The company reaffirmed adjusted EPS guidance of $0.75 to $0.79 and expects mid-single-digit revenue growth in the fourth quarter.
· Business
- Tactile Medical Raises 2026 Adjusted EBITDA Outlook to $50 Million-$52 Million
The company kept its revenue forecast at $360 million-$366 million, implying growth of about 9%-11% from 2025.
· Business
- Merit Medical Raises 2026 Non-GAAP EPS Outlook to $4.33-$4.37
Third-quarter revenue rose 8% to $416 million, while non-GAAP EPS advanced 22% and organic constant-currency revenue grew 9%.
· Business
- Utah Medical Products Q3 EPS Rises 6.8% as Sales Fall 12.1%
Net income increased 5.9% to $2.787 million as operating income rose despite lower gross profit.
· Business
- AngioDynamics Sets Fiscal 2027 Sales Outlook at $336 Million to $341 Million
Eric Honroth will become president and CEO effective Nov. 2, while Med Tech growth offsets flat Med Devices revenue expectations.
· Business
- Haemonetics Shares Rise 14% on CSL U.S. Supply Deal Update
CSL Limited expects to deploy Haemonetics devices throughout its U.S. plasma-collection centers under the agreement.
· Business
- AngioDynamics Beats Estimates With $80.92 Million Q1 Revenue
The medical-device company posted non-GAAP earnings of negative 4 cents per share and reaffirmed its fiscal 2026 outlook.
· Business